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Abstract
Introduction:  Chronic  obstructive  pulmonary  disease  (COPD)  is  a  disease  with  great  impact  on
the ability  to  carry  out  physical  activity.
Objective:  To  identify  the  main  factors  that  affect  physical  activity  in  the  daily  life  of  patients
with COPD.
Methods:  Physical  activity  in  daily  routine  has  been  evaluated  according  to  the  London  Chest
Activity of  Daily  Living  scale  (LCADL)  and  the  pedometer  counting  the  number  of  steps  per  day,
for a  period  of  three  days.  Fifty-ﬁve  male  patients  with  a  diagnosis  of  moderate  to  very  severe
COPD were  included  (aged  67  ±  9.6  years;  FEV1 50.8  ±  14.7%  predicted).
Results:  Patients  walked  on  average  4972  steps  per  day.  Very  severe  COPD  patients  (n  =  12)
walked much  less  than  severe  (n  =  21)  and  moderate  (n  =  22)  patients  (respectively  3079.8  versus
4853.5 and  6118.1  steps  per  day,  p  <  0.001).  The  number  of  steps  per  day  had  a  negative  corre-
lation with  age,  dyspnea  (mMRC),  depression,  BODE  index  and  pulmonary  hyperinﬂation;  and  a
positive correlation  with  the  distance  covered  in  the  six-minute  walk  test  (6MWT),  forced  expi-
ratory volume  in  the  ﬁrst  second  (FEV1),  carbon  monoxide  diffusion  capacity  (DLCO),  arterial
oxygen saturation  (SpO2)  and  body  mass  index  (BMI).
Conclusions:  The  main  factors  that  correlated  with  limited  physical  activity  in  daily  life  routine
of this  group  of  COPD  patients  were  dyspnea  and  6  min  walking  distance.  These  patients  form  a
sedentary group,  with  a  low  rate  of  daily  physical  activity,  which  is  more  evident  in  patients  with
GOLD spirometry  stage  IV.  Although  pedometer  is  simpler  and  less  accurate  than  other  devices,
it can  be  used  to  detect  signiﬁcant  restraints  daily  life  physical  activity  of  COPD  patients.
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PALAVRAS-CHAVE
Doenc¸a Pulmonar
Obstrutiva  Crónica;
Atividades  da  Vida
Diária;
Pedómetro
Fatores  que  inﬂuenciam  a  atividade  física  na  vida  diária  dos  doentes  do  sexo
masculino  com  doenc¸a pulmonar  obstrutiva  crónica
Resumo
Introduc¸ão:  A  Doenc¸a  Pulmonar  Obstrutiva  Crónica  (DPOC)  é  uma  doenc¸a  com  grande  impacto
na capacidade  de  realizar  atividade  física.
Objetivo:  Identiﬁcar  os  principais  fatores  que  inﬂuenciam  a  atividade  física  na  vida  diária  dos
doentes com  DPOC.
Métodos:  A  atividade  física  na  rotina  diária  foi  avaliada  de  acordo  com  a  escala  London  Chest
Activity of  Daily  Living  (LCADL)  e  a  quantiﬁcac¸ão  do  número  de  passos  por  dia  avaliada  com
pedómetro  durante  um  período  de  3  dias.  Foram  selecionados  55  doentes  do  sexo  masculino
com o  diagnóstico  de  DPOC  moderada  a  muito  grave  (com  67±9,6  anos  de  idade  e  volume
expiratório  forc¸ado  no  primeiro  segundo  (FEV1)  50,8±14,7%  do  previsto).
Resultados:  Os  doentes  andaram  uma  média  de  4.972  passos  por  dia.  Os  doentes  com  DPOC
muito grave  (n=12)  andaram  muito  menos  do  que  os  doentes  com  DPOC  grave  (n=21)  e  moderada
(n=22) (respetivamente,  3.079,8  versus  4.853,5  e  6.118,1  passos  por  dia,  p  <  0,001).  O  número
de passos  por  dia  apresentou  uma  correlac¸ão  negativa  com  a  idade,  dispneia  (mMRC),  depressão,
índice BODE  e  hiperinsuﬂac¸ão  pulmonar;  e  apresentou  uma  correlac¸ão  positiva  com  a  distân-
cia percorrida  na  prova  de  marcha  de  seis  minutos  (6MWT),  FEV1,  capacidade  de  difusão  do
monóxido de  carbono  (DLCO),  saturac¸ão  de  oxigénio  arterial  (SpO2)  e  índice  de  massa  corporal
(IMC).
Conclusões:  Os  principais  fatores  que  se  correlacionaram  com  a  limitac¸ão  da  atividade  física
na rotina  da  vida  diária  deste  grupo  de  doentes  com  DPOC  foram  a  dispneia  e  a  distância
percorrida  na  prova  de  marcha  dos  6  minutos.  Estes  doentes  formam  um  grupo  sedentário,
com uma  taxa  reduzida  de  atividade  física  diária,  o  que  é  mais  evidente  em  doentes  com
espirometria  de  estádio  GOLD  IV.  Embora  o  pedómetro  seja  mais  simples  e  menos  preciso  que
outros dispositivos,  pode  ser  usado  para  detetar  restric¸ões  signiﬁcativas  da  atividade  física  na
vida diária  dos  doentes  com  DPOC.
© 2013  Sociedade  Portuguesa  de  Pneumologia.  Publicado  por  Elsevier  España,  S.L.  Todos  os
direitos reservados.
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onitoring  of  the  daily  physical  activity  in  patients  with
OPD  has  been  a  subject  of  study,  since  physical  activity
s  known  to  be  reduced1,2 due  to  multifactorial  causes  and
orsened  prognosis.
The  present  recommendations3 point  out  the  beneﬁts  of
oderately  intense  daily  physical  activity  for  at  least  30  min
 times/week  (or  150  min/week)  and  considers  those  not
eeting  this  goal  as  insufﬁciently  active.
Physical  activity  in  daily  life  can  be  measured  with
edometers,4 which  evaluate  the  vertical  body  movement,
ounting  the  number  of  steps  during  a  certain  period  of  time,
uring  a  recommended  evaluation  period  of  three  days.5
lthough  less  accurate  than  accelerometers,  these  devices
rovide  a  low-cost  objective  measurement  of  walking,  a
aily  physical  activity  responsible  for  a  great  amount  of  the
otal  energy  expenditure.
Tudor-Locke  and  Bassett6 proposed  the  following  indices
f  physical  activity  measured  with  a  pedometer  in  adults:
ess  than  5000  steps  per  day  --  ‘‘sedentary’’;  5000--
499  steps  per  day  --  ‘‘low  active’’;  7500--10,000  steps  per
ay  --  ‘‘somewhat  active’’  and  more  than  10,000  steps
er  day  --  ‘‘active’’.
The  main  goal  of  this  study  was  to  identify  the  factors
hat  inﬂuence  physical  activity  in  the  daily  life  in  COPD
atients.  Secondary  goals  were:  (1)  to  ﬁnd  out  whether  there
c
(
o
gere  differences  in  physical  activity  according  to  airways
ow  limitation  (GOLD  spirometry  grade7);  (2)  to  compare
he  number  of  steps  per  day  measured  with  the  pedome-
er  and  daily  living  activities  (reported  by  London  Chest  of
ctivity  Daily  Living  scale)  and  (3)  to  relate  clinical,  nutri-
ional,  psychological,  lung  function  and  exercise  variables
ith  daily  living  activities  of  COPD  patients.
ethods
ample
his  study  included  55  moderate  to  very  severe7 COPD
atients,  followed  in  the  Pulmonology  Unit  and  selected
onsecutively  in  a  period  of  7  months.
The  inclusion  criteria  were:  male  sex;  smoking  history
bove  10  pack-years;  COPD  diagnosis;  FEV1/FVC%  ratio
ess  than  70%  and  FEV1 less  than  80%  of  predicted  post-
ronchodilation  and  stable  disease  (absence  of  exacerbation
r  change  in  treatment  in  the  last  three  months).  Exclu-
ion  criteria  were  other  conditions  that  could  also  cause
r  enhance  dyspnea  (e.g.  asthma,  cardiovascular  diseases),
onditions  that  could  impair  physical  activity  performance
e.g.  cerebrovascular,  osteoarticular  or  psychiatric  diseases)
r  already  taking  part  in  a  pulmonary  rehabilitation  pro-
ram.
ale  patients  133
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The  study  was  carried  out  at  the  Respiratory  Phys-
iopathology  Laboratory,  Centro  Hospitalar  de  Torres  Vedras,
after  being  approved  by  the  Centro  Hospitalar  de  Tor-
res  Vedras  Ethics  Committee,  and  after  obtaining  written
informed  consent  from  the  patients.
Characterization  of  the  sample
Patients  were  clinically  evaluated,  including  their  smoking
habits  and  the  modiﬁed  Medical  Research  Council  (mMRC)
dyspnea  scale  quantiﬁcation.  mMRC  is  formed  by  5  grades
(0  to  4),  the  highest  value  corresponding  to  the  greatest
limitation  caused  by  dyspnea  in  the  activities  of  daily  life.8
Anxiety  and  depression  were  investigated  using  the  hos-
pital  anxiety  and  depression  scale  (HADS).  This  scale  is
composed  of  14  items,  7  being  related  to  anxiety  and  7  to
depression,  with  a  maximum  possible  score  of  21  for  every
quotation.9
The  nutritional  assessment  was  based  on  the  body  mass
index  (BMI)  evaluation,  deﬁned  as  the  weight  in  kilos  divided
by  the  height  in  squared  meters.  According  to  the  adopted
reference  values,10 a  BMI  below  20  kg/m2 was  considered
low  weight,  from  20  to  24.9  kg/m2 normal  weight,  from  25
to  29.9  kg/m2 overweight  and  obesity  from  30  kg/m2.
Pulmonary  function  tests  at  rest  included  spirometry  with
bronchodilation  test,  evaluation  of  pulmonary  static  vol-
umes  by  plethysmography  and  carbon  monoxide  diffusion
capacity  by  the  single  breath  method  (Sensor  Medics,  model
AutoBox  Vmax  22,  Yorba  Linda,  CA,  USA,  for  all  lung  tests)
according  to  the  standard  methods.11,12,13
Two  6MWT  were  performed  according  to  the  standard
methods14 with  a  minimum  interval  of  30  min  between  them.
The  one  with  the  longest  distance  covered  was  chosen.  Arte-
rial  blood  gases  were  assessed  at  the  beginning  and  at  the
end  of  the  6MWT  (Gas  analyser  Elnor  Nova  Biomedical  Stat
Proﬁle  pHOx  Plus/c,  Waltham,  USA).  Oxygen  saturation  by
pulse  oximetry  and  dyspnea  by  the  modiﬁed  Borg  scale15
were  also  evaluated  at  rest,  in  the  beginning  and  immedi-
ately  after  6MWT.
At  the  end  of  these  evaluations,  the  BODE  index  was
calculated.16
Evaluation  of  physical  activity  in  daily  life
Physical  activity  in  daily  life  was  evaluated  according  to
LCADL  scale  and  the  number  of  steps  per  day,  on  three
consecutive  days,  between  Monday  and  Friday,  was  counted
using  the  pedometer.
LCADL  contains  15  activities  of  daily  living  (ADL)  items,
divided  into  four  sections  (self-care,  domestic,  physical  and
leisure),  where  the  patients  give  to  each  item  a  score  from
0  to  5,  mentioning  to  what  extent  dyspnea  interferes  with
these  15  activities.  It  is  possible  to  get  a  total  score  of
between  0  and  75.  The  higher  the  results  on  the  scale  the
greater  the  limitation  in  ADL.17,18
After  completing  the  scale,  a  pedometer  Geonaute  Dista
T300  was  given  to  each  patient,  who  then  placed  it  on  their
waistband  when  walking  (pedometer  had  to  be  removed
each  time  the  patient  takes  a  shower,  lies  in  bed  or  in  any
other  situation  which  might  damage  the  gear),  keeping  to
their  daily  routine  for  three  days.
t
h
t
iFigure  1  Average  number  of  steps  per  day.
tatistical  analysis
ata  are  expressed  as  mean  ±  standard  deviation  (SD).
ANOVAs  one-way  test  was  used,  followed  by  tests  of
ultiple  a  posteriori  comparisons  of  Tukey  to  assess  the  dif-
erences  in  physical  activity  in  daily  life  according  to  ﬂow
imitation  (GOLD  spirometry  grade).
We  compared  the  number  of  steps  per  day  measured  with
he  pedometer  and  LCADL  through  the  Spearman  correlation
oefﬁcient.  The  number  of  steps  per  day  was  a  dependent
ariable.  The  independent  variable  selection  was  achieved
y  Pearson’s  correlation  coefﬁcient  analysis.
Finally,  a  stepwise  multiple  linear  regression  analysis  was
one,  in  order  to  estimate  the  inﬂuence  of  the  variables
n  physical  activity  in  the  daily  routine,  according  to  the
edometer.  The  level  of  signiﬁcance  was  set  at  p  <  0.05.
All  analysis  was  done  with  SPSS  v.16.0  software  (Statisti-
al  Package  for  the  Social  Sciences)  for  Mac.
esults
he  clinical,  nutritional,  psychological,  lung  function  fea-
ures  as  well  as  features  of  physical  activity  of  the  sample
re  shown  in  Table  1.
In  the  evaluation  of  daily  life  activities  using  the  LCADL
cale,  there  were  differences  with  statistical  relevance
etween  the  very  severe  patients  (grade  IV)  and  the  patients
ith  moderate  COPD  (grade  II),  with  the  former  showing,  on
verage,  a  higher  total  score  in  the  LCADL  scale  (20.8  ±  5.1
ersus  15.9  ±  3.6,  p  <  0.027).
The  evaluation  of  physical  activity  in  daily  life  measured
ith  pedometer  in  all  groups  of  patients  showed  that  the
verage  number  of  steps  per  day  was  4972.4,  distributed
hrough  different  stages  of  the  disease  according  to  Fig.  1.
here  were  statistical  differences  between  patients  with
OPD  spirometry  stage  IV  and  patients  with  stages  II  and
II,  the  very  severe  patients  being  those  who  walk  less  (on
verage  3079.8  versus  4853.5  and  6118.1  steps  per  day,
 <  0.001).
Examining  the  linear  correlation  coefﬁcients  (Table  2),
he  number  of  steps  per  day  has  shown  a  negative  correla-
ion  with  age,  dyspnea,  depression,  BODE  index,  pulmonary
yperinﬂation  and  LCADL;  it  is  positively  correlated  with
he  distance  covered  and  with  minimal  oxygen  saturation
n  6MWT,  FEV1, DLCO,  and  BMI.
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Table  1  Clinical,  nutritional,  psychological,  respiratory  function  and  physical  activity  characterization.
GOLD  II  (n  =  22)  GOLD  III  (n  =  21)  GOLD  IV  (n  =  12)  (n  =  55)
Age  (years)  67.0  ±  12.2  67.9  ±  6.8  66.1  ±  8.6  67.2  ±  9.6
Smoking history  (pack-years)  54.8  ±  26.7  53.0  ±  26.7  65.0  ±  22.1  56.4  ±  25.7
BMI (kg  m−2)  28.1  ±  3.2  28.6  ±  4.6  26.0  ±  5.1  27.8  ±  4.2
mMRC dyspnea  1.9  ±  0.6  2.4  ±  1.1  3.3  ±  1.0  2.4  ±  1.0
Depression total  score  5.7  ±  2.8  5.1  ±  2.4  7.2  ±  3.3  5.8  ±  2.8
Anxiety total  score  6.6  ±  2.4  6.8  ±  3.5  7.0  ±  2.0  6.8  ±  2.8
BODE index  1.8  ±  1.2  3.9  ±  1.4  5.9  ±  1.5  3.5  ±  2.1
Pulmonary function
FEV1 (%  predicted) 66.6  ±  8.0 42.3  ±  4.9  36.9  ±  6.9  50.8  ±  14.7
FVC (%  predicted) 92.4  ±  9.0 70.3  ±  13.9 70.0  ±  17.0 79.1  ±  16.8
FEV1/FVC  (%) 56.8  ±  8.6 48.5  ±  8.7 43.0  ±  10.8 50.6  ±  10.5
TLC (%  predicted)  110.6  ±  13.4  107.5  ±  14.6  117.3  ±  16.4  110.9  ±  14.8
RV (%  predicted)  153.8  ±  42.1  172.7  ±  34.4  196.6  ±  36.5  170.4  ±  40.8
RV/TLC (%) 53.1  ±  11.4  61.9  ±  8.2  65.8  ±  5.7  59.2  ±  10.5
DLCO (%  predicted) 72.7  ±  24.2  63.5  ±  22.1  47.8  ±  16.5  63.8  ±  23.5
DLCO/VA (%  predicted) 69.5  ±  17.4  71.9  ±  17.6  52.1  ±  15.8  66.6  ±  18.6
PaO2 (mmHg) 79.5  ±  9.5 78.8  ±  8.0  65.7  ±  7.7  76.2  ±  10.1
PaCO2 (mmHg) 39.4  ±  3.6 41.0  ±  3.4 40.1  ±  3.9  40.2  ±  3.6
Exercise capacity
6MWD  (m)  391  ±  85.7  370  ±  72.7  268  ±  94.7  356  ±  94.5
SpO2 minimal  (%)  88.4  ±  5.6  87.3  ±  5.4  79.5  ±  7.0  86.0  ±  6.7
Initial dyspnea  (Borg)  0.2  ±  0.5  0.3  ±  0.7  1.3  ±  1.2  0.5  ±  0.9
Final dyspnea  (Borg)  1.3  ±  0.9  1.9  ±  1.3  3.4  ±  1.2  2.0  ±  1.4
Final HR  (bpm)  114.8  ±  20.7  127.3  ±  14.6  131.1  ±  24.3  123.2  ±  20.4
LCADL total  score  15.9  ±  3.6⊗ 17.8  ±  5.8  20.8  ±  5.1⊗ 17.7  ±  5.1
Steps/day 6118.1  ±  2217.5*  4853.5  ±  1668.2 3079.8  ±  1917.3* 4972.4  ±  2242.3
BMI: body mass index; mMRC dyspnea: modiﬁed Medical Research Council dyspnea scale; BODE: BODE index (B: body mass index; O:
obstruction; D: dyspnea; E: exercise); FEV1: forced expiratory volume in one second; FVC: forced vital capacity; TLC: total lung capacity;
RV: residual volume; DLCO: carbon monoxide diffusion capacity; DLCO/VA: DLCO corrected to alveolar volume; PaO2: arterial oxygen
pressure; PaCO2: carbon dioxide arterial pressure; 6MWD: six-minute walk distance; SpO2: arterial oxygen saturation; HR: heart rate;
bpm: beat per minute.
Values are shown as mean ± SD. Respiratory failure patients were classiﬁed as GOLD IV.
⊗ p < 0.027.
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In  order  to  test  the  contribution  of  every  variable  to
xplain  the  variance  with  the  number  of  steps  per  day  in
he  patients  with  COPD  studied,  we  set  a  stepwise  multiple
egression  analysis,  so  as  to  eliminate  redundant  variables.
o  this  effect,  all  variables  that  had  shown  relevant  correla-
ions  in  the  simple  linear  correlation  analysis  were  included
n  the  multiple  regression  analysis.
As  a  result,  we  got  a  model  where  the  signiﬁcant  variables
hat  helped  to  explain  the  number  of  steps  per  day  (64.2%
f  its  variance  --  R2 =  0.642)  were  dyspnea  (mMRC)  and  the
istance  covered  in  6MWT  (Table  3).
iscussion
n  this  study  we  identiﬁed  the  key  factors  related  to  physi-
al  activity  in  the  daily  life  of  a  group  of  COPD  patients  at
OLD  spirometry  stage  II  to  IV.  These  factors  were  dyspnea
nd  the  distance  covered  in  6MWT.  Moreover,  in  our  sample,
here  were  differences  between  patients  with  stage  IV  and
atients  with  moderate  and  severe  COPD  (stages  II  and  III),
he  most  severe  cases  being  those  patients  who  walk  less  in
t
d
pheir  daily  routine  (3079.8  steps  per  day)  when  compared  to
ess  severe  patients  (4853.5  steps  per  day)  and  the  moder-
te  ones  (6118.1  steps  per  day).  Even  our  moderate  COPD
atients  are  markedly  sedentary,  which  classiﬁes  them  as
ow  active,  as  set  out  by  Tudor-Locke  and  Bassett.6
Watz  et  al.19 also  veriﬁed  a  larger  reduction  in  COPD
atients’  daily  life  physical  activity  according  to  the  sever-
ty  of  the  disease,  but  present  at  all  COPD  stages,  compared
o  chronic  bronchitis  patients.
In  relation  to  LCADL  scale,  there  were  signiﬁcant  dif-
erences  between  COPD  stage  IV  (20.8)  and  COPD  stage  II
atients  (15.9);  the  most  severe  patients  were  those  who
howed  greater  restrictions  during  activities  of  daily  living.
Comparing  the  pedometer  and  LCADL  scale,  we  veriﬁed
 negative  and  moderate  correlation  (r  =  −0.499;  p  <  0.01)
howing  that  the  higher  the  ADL  restraint,  the  lower  the
aily  physical  activity  in  these  patients,  assessed  by
he  number  of  steps  per  day.
Among  the  factors  that  can  limit  physical  activity  in
aily  life,  dyspnea  is  known  to  be  rather  variable  in  this
opulation  and  its  origin  is  recognized  as  multifactorial.20
Factors  that  inﬂuence  physical  activity  in  the  daily  life  of  male  p
Table  2  Linear  correlation  coefﬁcients.
Variable  r  p
Age  −0.416 p  <  0.01
BMI 0.276  p  <  0.05
mMRC  dyspnea  −0.661  p  <  0.01
BODE  −0.741  p  <  0.01
Depression  total  score  −0.424  p  <  0.01
LCADL  −0.499  p  <  0.01
FEV1 0.493  p  <  0.01
RV −0.336  p  <  0.05
DLCO 0.551 p  <  0.01
6MWD  0.719 p  <  0.01
Minimal  SpO2 0.633 p  <  0.01
Dyspnea  (Borg)  −0.601  p  <  0.01
BMI: body mass index; mMRC dyspnea: modiﬁed Medical
Research Council dyspnea scale; BODE: BODE index (B: body
mass index; O: obstruction; D: dyspnea; E: exercise); LCADL:
London Chest Activity of Daily Living scale; FEV1: forced expira-
tory volume in one second; RV: residual volume; DLCO: carbon
monoxide diffusion capacity; 6MWD: six minute walk distance;
SpO2: arterial oxygen saturation.
Table  3  Multiple  regression  analysis.
R2 =  0.642 ˇ  p  value
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tmMRC  dyspnea  −0.406  <0.001
6MWD 0.520  <0.001
The  present  study  found  a  negative  and  moderate  correla-
tion  (r  = −0.661;  p  <  0.01)  between  dyspnea  (mMRC)  and  the
number  of  steps  per  day,  and  it  was  one  of  the  main  fac-
tors  that  contributed  to  its  variance  (ˇ  =  −0.406,  p  <  0.001),
reﬂecting  the  effect  of  the  downward  spiral  of  COPD,
derived  from  the  interaction  of  dyspnea,  inactivity  and  phys-
ical  deconditioning,  since  the  higher  the  dyspnea  is,  the
higher  the  ADL  restraint  and  the  lower  the  number  of  steps
per  day  will  be.  Dyspnea  assessed  on  the  Borg  scale  was
also  negatively  correlated  with  the  number  of  steps  per  day,
suggesting  that  the  degree  of  dyspnea  developed  in  the  walk
test  is  similar  to  the  one  realized  in  ADL  evaluated  by  mMRC
scale.21
Another  determining  factor  for  the  variation  of  the  num-
ber  of  steps  per  day  was  the  distance  covered  in  6MWT
(ˇ  =  0.520,  p  <  0.001).  The  high  linear  association  between
the  daily  physical  activity  assessed  with  the  pedometer  and
the  distance  covered  in  6MWT  (r  =  0.719;  p  <  0.001)  suggests
that  the  pedometer  gives  a  valid  measurement  of  physical
activity  in  this  group  with  functional  restraint,  quantifying
walking,  which  is  the  most  common  and  available  physi-
cal  activity  modality  and  seems  to  strongly  contribute  to
the  level  of  total  daily  physical  activity.22 Furthermore,
this  close  relationship  between  the  pedometer  and  6MWT
is  comparable  to  what  Fabio  Pitta  et  al.  also  showed:  the
distance  covered  by  6MWT  (functional  exercise)  has  a  high
correlation  with  the  physical  activity  level  that  patients
develop  in  daily  life.1 In  Pitta’s  study,  activity  was  also
positively  related  to  accelerometer  data,  showing  that  a
reduction  in  the  distance  covered  in  6MWT  is  the  best  marker
of  inactivity  during  the  daily  life  of  patients  with  COPD.
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In  this  study,  FEV1 was  related  in  a  positive  and  moder-
te  way  to  the  number  of  steps  per  day  (r  =  0.493;  p  <  0.01),
s  is  also  referred  to  in  other  studies.1,2,19 Other  authors,
owever,  have  not  found  any  correlation  between  physi-
al  activity  and  the  severity  of  COPD,  probably  owing  to
ifferences  in  the  degree  of  obstruction,  sample  size  and
he  instruments  used  to  assess  physical  activity  in  daily
outine.23--26
As  also  mentioned  in  other  papers,27--31 most  of  the
atients  in  this  sample  (80%)  showed  pulmonary  hyperinﬂa-
ion  at  rest.  As  one  of  the  most  important  factors  associated
ith  dyspnea  in  patients  with  COPD,  in  our  study,  pulmonary
yperinﬂation  also  showed  a  negative  and  moderate  cor-
elation  with  the  daily  physical  activity  assessed  by  the
edometer  (r  =  −0.511;  p  <  0.01).  However,  it  did  not  con-
ribute  to  the  variance  in  the  number  of  steps  per  day  in  the
ultiple  regression  analysis.
Concerning  gas  exchanges,  DLCO  was  positively  corre-
ated  with  the  number  of  steps  per  day.  Other  authors32,33
lso  found  a  signiﬁcant  contribution  of  DLCO  to  the  physical
ctivity  performance  of  COPD  patients.
In  this  study,  76%  of  the  patients  showed  arterial  oxygen
esaturation  during  the  6MWT  and  the  minimal  SpO2 corre-
ated  positively  with  the  number  of  steps  per  day  (r  =  0.633;
 <  0.01)
Age  was  negatively  correlated  (r  =  −0.416;  p  <  0.01)  with
he  level  of  physical  activity  registered  by  the  pedometer,
uggesting  that  older  people  are  less  active,  walking  fewer
teps  per  day,  as  has  already  been  shown.34
BMI  was  associated  in  a  positive,  signiﬁcant  and  weak  way
r  =  0.276;  p  <  0.05)  to  the  number  of  steps  per  day,  as  also
hown  in  other  studies.2,35
The  BODE  index  showed  a negative  and  strong  correla-
ion  with  the  number  of  steps  per  day  (r  =  −0.741;  p  <  0.01).
owever,  in  the  model  of  multiple  linear  regressions,  its
nﬂuence  on  the  variance  of  the  number  of  steps  per  day
oses  statistical  relevance.
Psychological  factors,  such  as  anxiety  and  depression,
ave  been  described  as  frequent  in  these  patients,  con-
ributing  to  a  lower  level  of  physical  activity,  even  after
ell  structured  pulmonary  rehabilitation  programs.  In  this
ample,  the  prevalence  found  was  much  lower  than  in  other
tudies,36--39 but  depression  was  correlated  in  a  negative  but
oderate  way  with  the  number  of  steps  per  day  (r  =  −0.424;
 <  0.01).  Besides  dyspnea  and  exercise  capacity,  psycho-
ogical  factors  such  as  anxiety  and  depression,  behavioral
actors  such  as  lack  of  motivation  and  self-efﬁcacy,  and
ocial  and  environmental  barriers  are  all  capable  of  inﬂuenc-
ng  physical  activity  and  further  studies  should  be  directed
t  their  identiﬁcation  and  management.
There  are  some  limitations  to  consider  in  this  study.  Since
he  sample  only  included  male  patients,  we  cannot  apply  the
esults  to  the  female  population.  Although  the  prevalence
f  COPD  is  increasing  in  women,  in  Portugal  it  is  still  much
ore  prevalent  in  men  [18.7  versus  10.5%  --  Bárbara  et  al.43].
hen  recruiting  patients  for  this  study,  there  were  so  few
OPD  female  patients  that  it  would  not  have  been  possible
o  generalize  the  conclusions  from  these  gender  patients.
oreover,  if  there  had  been  a  control  group  it  would  have
llowed  us  to  compare  the  patients  with  another  patient
opulation  group  or  to  healthy  people,  thus  marking  their
evel  of  daily  physical  activity.
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In  this  study  the  LCADL  scale  showed  a  low  average  total
core  (17.7),  probably  because  the  sample  was  formed  by  a
ale  population,  73%  of  which  stated  they  did  not  do  any
ind  of  household  tasks,  or  because  most  of  the  patients
nderestimated  the  severity  of  their  disease.18,39--42 While
ost  of  them  considered  themselves  as  suffering  from  a  light
yspnea,  their  average  number  of  steps  per  day  was  low,
howing  how  inactive  they  are  in  their  daily  lives.
Concerning  pedometer  data,  it  is  not  possible  to  con-
rol  possible  sources  of  error,  such  as  low  walking  speed,
orgetting  or  incorrectly  setting  the  equipment  or  vibra-
ions,  e.g.  when  driving  a  car  or  a  bicycle.  These  errors
re  assumed  to  have  been  reduced  by  keeping  with  a three-
ay  record,  as  recommended.5 As  was  demonstrated  by  Van
emoortel  et  al.  in  a  recent  systematic  review  (PROac-
ive  consortium),  uniaxial  pedometers  are  signiﬁcantly  less
ccurate  than  multisensor  devices,  particularly  at  slow  walk-
ng  speeds.44 Therefore  the  results  of  our  study  should  be
reated  cautiously.
In conclusion,  the  main  factors  that  contributed  to  phys-
cal  activity  restraint  in  male  COPD  patients  daily  life
ssessed  with  a  pedometer  were  dyspnea  (mMRC)  and  the
ow  functional  exercise  capacity  (distance  covered  in  the
MWT).  These  results  point  to  the  need  for  a  better  con-
rol  of  these  two  issues  in  clinical  practice.  These  patients
re  markedly  inactive  and  show  limitations  in  ADL,  becom-
ng  these  features  more  evident  in  patients  with  very  severe
OPD.
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